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calculated using Cox regression models while adjusting for 
potential confounders.
Results During a follow-up period of 22 years, we iden-
tified 211 incident cases of LC. A higher zinc intake was 
associated with 42 % reduction in risk of LC (top ter-
tile vs. first tertile: HR 0.58, 95 % CI 0.35; 0.94, P-for 
trend = 0.039). Similarly, high intake of iron was associ-
ated with reduced risk of LC (top tertile vs. first tertile: HR 
0.58, 95 % CI 0.37; 0.92, P-for trend = 0.021). There was 
no association between dietary intake of calcium, copper, 
magnesium and selenium and LC risk.
Conclusions Our results suggest that dietary zinc and iron 
intake are associated with reduced risk of LC. No evidence 
was found for an association between calcium, copper, 
magnesium and selenium intake and LC risk.
Keywords Zinc · Iron · Calcium · Copper · Magnesium · 
Selenium · Lung cancer
Abbreviations
BMI  Body mass index
DHD  Dutch healthy diet
FFQ  Food frequency questionnaire
ICD  International classification of disease
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Introduction
Lung cancer is the leading cause of cancer mortality world-
wide and incurs the highest economic burden of all cancers 
[1, 2]. Lung cancer is a disease for which environmental fac-
tors (e.g., smoking, gender, asbestosis and pollution) play 
an important role [3]. Besides smoking, emerging evidence 
Abstract 
Objective Limited data are available on the role of min-
eral intake in the development of lung cancer (LC). We 
investigated whether dietary calcium, copper, iron, mag-
nesium, selenium and zinc intake were associated with LC 
risk.
Methods We analyzed data from 5435 participants of the 
Rotterdam Study, a prospective population-based cohort 
study among subjects aged 55 years and older. At base-
line (1990–1993), diet was measured by a validated food 
frequency questionnaire. LC events were diagnosed on 
the basis of pathology data and medical records. Hazard 
ratios (HRs) on LC for energy-adjusted mineral intake were 
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also suggest that dietary factors may have an impact on the 
risk of lung cancer [3]. To date, limited evidence exists on 
the role of dietary mineral intake, such as calcium, copper, 
iron, magnesium, selenium and zinc in the development of 
lung cancer [4–8]. Copper, magnesium, selenium and zinc 
are essential dietary minerals for maintaining the integrity 
of DNA by preventing oxidative DNA damage [9–12]. On 
the other hand, iron deficiency, as well as iron overload, may 
lead to oxidative DNA damage [13]. Evidence from in vitro 
and experimental studies suggests that DNA damage and 
defects in DNA repair mechanisms can predispose to cancer 
development [14]. Likewise, epidemiological studies have 
shown that DNA repair capacity is associated with increased 
lung cancer risk [3, 15, 16]. Calcium is another important 
mineral involved in processes of cell proliferation and car-
cinogenesis through cell signaling and cell cycle regulation 
[17]. However, previous studies evaluating the relationship 
between dietary mineral intake and lung cancer risk have 
shown inconsistent results [4, 5, 18]. Moreover, the most 
recent report from the World Cancer Research Fund con-
cluded that current evidence is still insufficient to allow any 
dietary recommendations for calcium, copper, iron, magne-
sium, selenium and zinc to reduce the risk of lung cancer [3].
The present study aimed to investigate whether dietary 
intake of these minerals was associated with lung cancer 
risk in a prospective population-based cohort study in the 
Netherlands.
Subjects and methods
Study population
This study was embedded in the first cohort of The Rot-
terdam Study (RS), a prospective population-based cohort 
study that started in 1990 with the aim to examine the fre-
quency and determinants of diseases in elderly [19, 20]. 
The rationale and design of the RS are described elsewhere 
[19, 20]. Trained research assistants collected data on cur-
rent health status, use of medication, and medical history, 
lifestyle, and risk indicators for chronic diseases during an 
extensive home interview at baseline (1990–1993). Subse-
quently, the participants visited the study center for detailed 
clinical examinations and assessment of diet. Follow-up 
visits were held every 3–5 years [19]. The Medical Ethics 
Committee of the Erasmus Medical Center approved the 
study, and written consent was obtained from all partici-
pants. Out of the initial cohort (N = 7983), 6521 who vis-
ited the study center at baseline were eligible for a dietary 
interview. We excluded 1086 (17 %) participants without 
reliable dietary data (i.e., no dietary data were collected 
from nursing home residents, and dietary data were consid-
ered as unreliable by the dietician, e.g., when subjects did 
not fully cooperate during the dietary interview). There-
fore, 5435 participants were included in the final analysis 
(Fig. 1).
Assessment of dietary intake
During the first home interview (1990–1993), participants 
completed a checklist that included foods and drinks they 
had consumed at least twice a month during the preced-
ing year, as well as dietary habits, use of supplements, and 
prescribed diets. Next, during their visit to the research 
center, they underwent a standardized interview with a 
dietitian based on the checklist, using a 170-item semi-
quantitative food frequency questionnaire [21]. A valida-
tion study comparing this questionnaire with a 2-week food 
diary demonstrated reproducible and valid estimates; Pear-
son’s correlation after adjustment for age, sex, energy and 
Fig. 1  Flow chart of partici-
pants in the study, the Rotter-
dam Study, 1989–1993
Participants Eligible for Dietary 
Interview in the First Wave of the 
Rotterdam Study (1990- 1993) 
(n = 6,521) 
1,086 Participants Excluded 
  No information on nutrition intake  
or Unreliable data  
Participants with Baseline Information 
about Nutritional Intake and Lung 
Cancer Follow-up 
(n = 5,435) 
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within-person variation were between 0.44 and 0.85 for 
macro- and micronutrients as described in detail previously 
[21]. Specifically, adjusted Pearson’s correlation coefficient 
was 0.44 for iron, 0.54 for zinc, 0.71 for selenium and 0.72 
for calcium, while the result for copper was not reported. 
Energy and nutrient intake were estimated based on fre-
quency of consumption and standardized portion sizes and 
using Dutch food composition table of 1993 and 1998 [22, 
23] (heme and non-heme iron was not included in the 1993 
table; therefore, the 1998 table was used). Data on zinc, 
iron (total iron, heme and non-heme iron), magnesium, 
selenium, copper and calcium were available.
Follow‑up and case identification
Follow-up of each participant began on the date at which 
baseline dietary intake was assessed (1989–1993) and 
ended on the date of lung cancer diagnosis, death, loss 
to follow-up or administrative censoring (31 December 
2011), whichever occurred first. Two research physicians 
independently assessed the diagnoses and the type of lung 
cancer on the basis of pathology data and medical records. 
All events were pathology proved and classified according 
to the International Classification of Disease (ICD), tenth 
edition.
Covariates assessment
The following covariates measured at baseline were con-
sidered as potential confounders: age; sex; smoking status 
(never smokers, former smokers <15 pack-years, former 
smoker ≥15 pack-years, current smoker <27.5 pack-years, 
current smoker ≥27.5 pack-years), use of alcohol (grams 
of ethanol per day); education level (low: primary educa-
tion, intermediate: secondary general or vocational educa-
tion, or high: higher vocational education or university); 
income level (low, intermediate or high), unprocessed 
red meat intake; processed red meat intake; total energy 
intake; use of hormone replacement therapy and use of 
minerals supplements (self-reported at baseline home 
interview); diabetes mellitus (defined as a fasting serum 
glucose level ≥11 mmol/L or the use of glucose lowering 
drugs); family history of cancer and Dutch Healthy Diet-
index (DHD-index) (to take into account the overall dietary 
quality, DHD-index represents compliance to the Dutch 
Guidelines for a Healthy Diet as assessed from the FFQ at 
baseline [24]). Baseline physical height and body weight 
were measured with the participants standing without shoes 
and heavy outer garments. Body mass index, calculated as 
weight divided by height squared (kg/m2), was also consid-
ered as confounder. Physical activity, assessed in the third 
round (1997–1999) of the Rotterdam Study by an adapted 
version of the Zutphen Physical Activity Questionnaire and 
the LASA Physical Activity Questionnaire [25, 26], was 
considered as confounder as well.
Statistical analysis
Age- and sex-adjusted (crude) and multivariable Cox pro-
portional hazards models were computed to estimate haz-
ard ratios (HRs) and 95 % confidence intervals (CIs) for 
each tertile of mineral intake compared with the lowest ter-
tile as the reference category. All dietary intake data were 
energy-adjusted by using the residual method [27]. In addi-
tion to age and gender, multivariable models were further 
adjusted for body mass index (BMI) (continuous), smok-
ing (never smokers, former smokers <15 pack-years, for-
mer smoker ≥15 pack-years, current smoker <27.5 pack-
years, current smoker ≥27.5 pack-years), alcohol intake 
(continuous), education level (low, intermediate, high), 
income (low, intermediate, high), energy-adjusted unpro-
cessed red meat (continuous), energy-adjusted processed 
red meat (continuous), total energy intake (continuous), use 
of hormone replacement therapy (HRT) (yes vs. no), preva-
lent diabetes mellitus (yes vs. no), family history of can-
cer (yes vs. no), Dutch Healthy Diet-index (DHD-index) 
(continuous), minerals supplemental use (yes vs. no) and 
physical activity (continuous). Due to significant correla-
tions between dietary minerals (Supplemental Table 1), 
we mutually adjusted for the other selected minerals in the 
multivariable model. To examine whether the association 
between dietary minerals intake and lung cancer differed 
by sex and smoking status, we tested for statistical inter-
action by adding a multiplicative interaction term (min-
eral intake x sex/smoking) to the age- and gender-adjusted 
model. In case of significant effect modification, results 
were presented stratified by sex or by smoking status (for-
mer/current smokers and ever smokers). All the values pre-
sented were two-sided, and P < 0.05 was considered sta-
tistically significant. To adjust for potential bias associated 
with missing data, a multiple imputation procedure was 
used for missing covariates (N = 5 imputations). For the 
pooled regression coefficients (β) and 95 % CIs, we used 
Rubin’s method [28].
Since high correlations between zinc and iron intake 
with red and processed meat were present (Table 2) but 
red meat intake has also been reported to be associated 
with an increased risk of lung cancer [29], we did a sensi-
tivity analysis by excluding red and processed meat from 
the multivariable model. To look if different sources of 
iron had different role, we further examined the association 
between heme and non-heme iron with lung cancer risk. To 
evaluate whether change in diet due to early signs of lung 
cancer may have influenced our results and whether miner-
als supplementation could have influenced our results, we 
repeated the analysis by excluding subjects who developed 
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lung cancer in the first 2 years of follow-up and by exclud-
ing subjects that used any mineral supplementation. To 
investigate whether the results are different for the dif-
ferent subtypes of lung cancer, we examined the associa-
tion of mineral intake with non-small cell lung cancer and 
other histologic subtypes. Also, a sensitivity analysis was 
preformed substituting smoking status categorized in five 
categories with smoking status categorizes into ever/form-
ers versus current smokers. Furthermore, we restricted the 
main analysis only to subjects who reported to be ever or 
former smokers. All the P values presented were two-sided, 
and P < 0.05 was considered statistically significant. All 
analyses were done using SPSS statistical software (SPSS, 
version 21.0; SPSS Inc, Chicago, Illinois).
Results
During a mean follow-up time of 15.2 years, a total of 
211 subjects developed lung cancer (128 cases in men and 
83 cases in women). Baseline characteristics are listed in 
Table 1. Mean total dietary intake of minerals was as fol-
lows: zinc: 10.6 ± 2.7 mg/day; iron: 11.9 ± 2.9 mg/
day; magnesium: 306.2 ± 74.8 mg/day; selenium: 
32.7 ± 10.5 µg/day: copper: 1.2 ± 0.5 mg/day; calcium: 
1125.5 ± 402.8 mg/day.
Specific dietary food intakes that significantly con-
tributed to zinc, iron, magnesium, selenium, copper and 
calcium intake are shown in Table 2. The Pearson (r) cor-
relations of 0.51, 0.45 and 0.42 were found between zinc 
intake and, respectively, processed and red meat, total dairy 
and wholegrain (Table 2). The correlations of iron with the 
specific dietary foods intake (Table 2) showed the highest 
correlations for wholegrain and processed and red meat 
(r = 0.51, 0.45, respectively). The main food contributor 
for magnesium, selenium, copper and calcium were who-
legrain (r = 0.57), fish (r = 0.62), processed and red meat 
(r = 0.28) and total dairy, respectively (r = 0.86). The 
overall variance explained by these food items for zinc, 
iron, magnesium, selenium, copper and calcium intake var-
ied from 27 % for copper to 80 % for calcium (Table 2).
Dietary intake of minerals and lung cancer risk
A higher zinc intake was associated with 42 % reduction 
in the risk of lung cancer (top tertile vs. first tertile: HR 
0.58, 95 % CI 0.35; 0.94, P-for trend = 0.039, Table 3) 
after adjustment for age, sex, alcohol intake, BMI, smok-
ing status, physical activity, DHD-index, processed and 
unprocessed red meat, energy intake, HRT, presence of 
diabetes mellitus, socioeconomic status, family history of 
cancer and dietary intake of other minerals. Similarly, high 
intake of iron was associated with reduced risk for lung 
cancer (in multivariable adjusted models: top tertile vs. first 
tertile: HR 0.58, 95 % CI 0.37; 0.92, P-for trend = 0.021, 
Table 3). No significant hazard ratios were found in the 
fully adjusted models for the association between dietary 
magnesium, calcium selenium and copper intake and the 
risk of lung cancer (Table 3).
Effect modification by gender and smoking
Significant interaction terms with gender were observed 
for dietary iron intake (P-interaction = 0.027) and 
Table 1  Selected characteristic of study participants (n = 5435)
DHD-index Dutch healthy diet-index
a Mean ± SD (all such values)
b Median; interquartile range in parentheses (all such values)
Characteristics Value
Age, years 70.5 ± 5.9a
Female, n (%) 59.1 (3210)
Smoking status, n (%)
 Never 1838 (33.8)
 Former smokers 2334 (42.9)
 Current smokers 1263 (23.3)
 Physical activity (min/week) 2550.50 ± 1133.1
 Alcohol intake, g/day 3.44 (14.7)b
Education level, n (%)
 Low 2830 (52.1)
 Medium 2140 (39.4)
 High 465 (8.6)
Income, n (%)
 Low 1265 (23.3)
 Medium 2415 (44.4)
 High 1755 (32.3)
BMI (kg/m2) 26.33 ± 3.64
DHD-index 48.24 ± 10.10
Unprocessed red meat (g/day) 74.37 ± 47.80
Processed red meat (g/day) 21.94 ± 18.75
Total energy intake (kcal/day) 1974.2 ± 502.6
Hormone replacement therapy n (%) 85 (1.6)
Diabetes mellitus 517 (9.5)
Mineral supplemental use, n (%) 101 (1.9)
Family history of cancer, n (%) 2804 (51.6)
Zinc intake (mg/day) 10.6 ± 2.7
Iron intake (mg/day) 11.9 ± 2.9
Heme iron intake (mg/day) 2.3 ± 0.98
Non-heme iron intake (mg/day) 8.8 ± 2.4
Magnesium intake (mg/day) 306.2 ± 74.8
Selenium intake (µg/day) 32.7 ± 10.5
Copper (mg/day) 1.2 ± 0.5
Calcium intake (mg/day) 1125.5 ± 402.8
Eur J Nutr 
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copper (P-interaction = 0.029). After stratification by 
gender, the inverse association between dietary iron 
intake and lung cancer was only observed in men (top 
tertile vs. first tertile: HR 0.49, 95 % CI 0.28; 0.85, P-
for trend = 0.016, Supplemental Table 2–3) but not 
in women (Supplemental Table 2-3). No consistent 
results were found for dietary copper in either gen-
der (Supplemental Table 2–3). No statistically signifi-
cant interactions were observed between dietary zinc 
intake (P-interaction = 0.49), magnesium (P-interac-
tion = 0.42) or calcium intake (P-interaction = 0.34) 
and gender (Supplemental Table 2–3). Also, no signifi-
cant interaction terms were observed for any of the min-
erals and smoking status (P-interactions varied from 
0.16 to 0.97) (data not shown).
Additional analysis
When the results were not adjusted for red meat, the inverse 
associations between zinc intake (top tertile vs. first tertile: 
HR 0.68, 95 % CI 0.44; 1.08, P-for trend = 0.12,) and iron 
intake (top tertile vs. first tertile: HR 0.65, 95 % CI 0.42; 
1.02, P-for trend = 0.06,) and the risk of lung cancer were 
not significant. Heme iron intake was inversely associated 
with lung cancer risk (in multivariable adjusted models: top 
tertile vs. first tertile: HR 0.58, 95 % CI 0.39; 0.87, P-for 
trend = 0.01, Fig. 2), whereas no association was found 
between non-heme iron and lung cancer risk (in multivari-
able adjusted models: top tertile vs. first tertile: HR 0.94, 
95 % CI 0.59; 1.51, P-for trend = 0.84, Fig. 2). Additional 
analyses showed that the association between heme iron 
Table 3  HRs of lung cancer 
by categories of dietary mineral 
intake
HR hazard ratio, CI confidence interval
Model 1: Adjusted for age and sex
Model 2: Model 1 + alcohol intake(continuous), body mass index (continuous), smoking status (never 
smokers, former smokers <15 pack-years, former smoker ≥15 pack-years, current smoker <27.5 pack-
years, current smoker ≥27.5 pack-years), physical activity(continuous), Dutch healthy diet-index (continu-
ous), dietary processed meat intake (continuous), dietary unprocessed red meat intake(continuous), total 
energy intake (continuous), hormone replacement therapy (yes vs. no), diabetes mellitus (yes vs. no), edu-
cation status(low, intermediate, high), income status (low, intermediate, high), total energy adjusted sum of 
other minerals (excluding the mineral under investigation) (continuous) and family history of cancer (yes 
vs. no)
N = 5435 Tertile 1 Tertile 2 Tertile 3 Continuous P trend
Dietary zinc intake
Cases, n 83 77 51
 Model 1 HR, 95 % CI 1.00 0.93 (0.68, 1.27) 0.57 (0.40, 0.81) 0.89 (0.83, 0.96) 0.002
 Model 2 HR, 95 % CI 1.00 1.02 (0.72, 1.46) 0.58 (0.35, 0.94) 0.88 (0.80, 0.98) 0.039
Dietary iron intake
 Cases, n 85 65 61
 Model 1 HR, 95 % CI 1.00 0.73 (0.53, 1.01) 0.60 (0.43, 0.84) 0.94 (0.89, 0.997) 0.003
 Model 2 HR, 95 % CI 1.00 0.80 (0.56, 1.15) 0.58 (0.37, 0.92) 0.94 (0.86, 1.04) 0.021
Dietary magnesium Intake
 Cases, n 88 60 63
 Model 1 HR, 95 % CI 1.00 0.68 (0.49, 0.95) 0.66 (0.47, 0.91) 0.997 (0.994, 0.999) 0.011
 Model 2 HR, 95 % CI 1.00 0.80 (0.57, 1.14) 0.84 (0.56, 1.27) 0.998 (0.995, 1.001) 0.38
Dietary selenium intake
 Cases, n 70 62 79
 Model 1 HR, 95 % CI 1.00 0.94 (0.67, 1.32) 1.16 (0.84, 1.61) 1.008 (0.993, 1.023) 0.35
 Model 2 HR, 95 % CI 1.00 1.06 (0.74, 1.52) 1.39 (0.97, 1.99) 1.011 (0.996, 1.027) 0.07
Dietary copper intake
 Cases, n 75 67 69
 Model 1 HR, 95 % CI 1.00 0.95 (0.68, 1.33) 0.97 (0.69, 1.34) 1.17 (0.999, 1.37) 0.83
 Model 2 HR, 95 % CI 1.00 1.33 (0.93, 1.91) 1.23 (0.84, 1.81) 1.20 (0.91, 1.06) 0.28
Dietary calcium intake
 Cases, n 90 64 57
 Model 1 HR, 95 % CI 1.00 0.79 (0.57, 1.08) 0.72 (0.51, 1.004) 1.000 (0.999, 1.000) 0.047
 Model 2 HR, 95 % CI 1.00 0.89 (0.59, 1.33) 0.76 (0.40, 1.45) 0.996 (0.889, 1.115) 0.42
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intake and lung cancer risk was not significant when the 
results were not adjusted for red meat (top tertile vs. first 
tertile: HR 0.75, 95 % CI 0.53; 1.07, P-for trend = 0.11). 
Substitution of smoking status as five categories into smok-
ing categorized as ever/formers vs. current smokers or 
restriction of the main analysis among subjects who were 
ever/former smokers (total number = 4172, number of 
lung cancer cases = 90) did not materially affect any of the 
associations (data not shown).
All associations that were statistically significant in the 
main analysis remained unchanged in terms of statistical 
significance in sensitivity analyses when excluding subjects 
who used mineral supplements (n = 101) (data not shown). 
Similarly, exclusion of lung cancer cases that occurred dur-
ing the first 2 years of follow-up (n = 24) from our analy-
sis did not substantially affect our results (Supplemental 
Table 4). Furthermore, the associations were not signifi-
cantly different when the subtypes of lung cancer were 
examined separately (Supplemental Table 5–6).
Discussion
In this prospective population-based cohort study, we found 
that dietary intake of zinc and iron was associated with a 
decreased risk of lung cancer. In contrast, we found no evi-
dence that dietary intake of calcium, copper, magnesium 
and selenium was associated with lung cancer risk. Epi-
demiological studies evaluating the role of dietary mineral 
intake on lung cancer risk have reported inconsistent results 
[4–7, 18]. As a result, no consensus has been reached by 
the WCRF [3].
In our study, the highest tertile of zinc intake was asso-
ciated with 42 % reduction in the risk for lung cancer, 
suggesting a beneficial role of dietary zinc intake on lung 
carcinogenesis. Similar to our findings, three large case–
control studies reported an inverse association between zinc 
intake and lung cancer risk with risk reductions in the same 
magnitude [5, 6, 16]. Moreover, a recent observation from 
Hashemian et al. [30] showed that zinc intake can reduce 
the risk of esophageal cancer. However, findings from two 
prospective studies investigating the association between 
zinc intake and lung cancer were inconsistent; one prospec-
tive study based on 482,875 subjects with a mean follow-up 
of 7 years showed no beneficial role of dietary zinc intake 
on lung cancer [4], whereas another study conducted in 
34,708 postmenopausal women with 16 years of follow-up 
showed that there was no association between zinc intake 
and lung cancer overall, but a high dietary zinc intake may 
decrease the risk of lung cancer among women who con-
sume high-dose vitamin C supplements [7]. In contrast 
to our study, the previous two prospective studies did not 
adjust for red meat, which can explain the difference in the 
reported results. As shown in our sensitivity analysis, when 
the results were not adjusted for red meat, the beneficial 
inverse association between dietary zinc intake and lung 
cancer was not significant. These results may imply that 
zinc from food sources other than red meat may be protec-
tive against lung cancer. Several mechanisms may explain 
the beneficial role of zinc on lung carcinogenesis. Zinc has 
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Fig. 2  Multivariable HRs of lung cancer by categories of dietary 
heme iron and non-heme iron intake. HRs (95 % CI) were estimated 
by using Cox’s proportional hazard model adjusted for age, gender, 
alcohol intake (continuous), body mass index (continuous), smok-
ing status (never smokers, former smokers <15 pack-years, former 
smoker ≥15 pack-years, current smoker <27.5 pack-years, current 
smoker ≥27.5 pack-years), physical activity (continuous), Dutch 
healthy diet-index (continuous), dietary processed meat intake (con-
tinuous), dietary unprocessed red meat intake (continuous), total 
energy intake (continuous), hormone replacement therapy (yes vs. 
no), diabetes mellitus (yes vs. no), education status (low, interme-
diate, high), income status (low, intermediate, high), total energy 
adjusted sum of other minerals (excluding the mineral under investi-
gation) (continuous), family history of cancer (yes vs. no) and heme 
or non-heme iron (according to the exposure under investigation). HR 
hazard ratio, CI confidence interval
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been shown to protect against free radicals and retard oxi-
dative processes [31]. Also, zinc plays an important role 
in DNA repair, protein synthesis and immune functioning 
[10, 31].
We observed a beneficial role of dietary iron on lung 
cancer risk, which was mainly driven by heme iron inde-
pendent of red meat intake. Epidemiological results of total 
dietary iron and heme iron intake and lung cancer risk are 
mixed. Our results for dietary iron intake are in agreement 
with the findings from the NIH-AARP Diet and Health 
Study, a prospective study with 7052 lung cancer cases, 
which showed that the higher intake of dietary iron was 
associated with a significant reduced risk of lung cancer 
of 13 % [4]. A risk reduction ranging from 19 to 34 % for 
total iron intake was found in a case–control study with 
1139 cases [16]. In another case control study, dietary iron 
intake was associated with an increased risk of lung can-
cer, whereas heme iron was associated with a decreased 
risk [5]. Similarly, in our study, heme iron was associated 
with a lower risk of lung cancer. However, a meta-analysis 
of three prospective studies on heme iron and lung cancer 
did not find any clear evidence for a beneficial role of heme 
iron [32]. Several factors may explain the discrepancies 
among reported results on dietary iron intake and lung can-
cer in epidemiological studies. First, the variation could be 
partly due to the complexity of assessing heme iron intake. 
A recent review on heme iron and lung cancer risk reported 
that from the total number of studies evaluating heme iron 
intake and lung cancer risk, only two studies used a spe-
cific food composition database [33, 34]. Second, different 
animal sources of heme iron such as poultry or fish have 
been associated with a decreased lung cancer risk [35, 36], 
whereas red meat is associated with an increased risk [33]. 
In the current investigation, we adjusted for red meat; there-
fore, it can be speculated that the observed beneficial role 
of heme iron may be due to other animal dietary sources. 
In addition, no association with heme iron was found when 
results were not adjusted for red meat. However, the exact 
mechanism for this observed protective effect of heme iron 
remains unclear. Last, inconsistent results between studies 
may be also due to different levels of dietary intake of min-
erals across studies, including iron intake [5, 18].
We found no role of dietary calcium, copper, magne-
sium and selenium intake on lung cancer risk. The asso-
ciation between these minerals and lung cancer has been 
investigated in few prospective studies with conflicting 
results. Our finding of no association of dietary magne-
sium intake and lung cancer risk is in agreement with the 
results of two previous cohort studies [18, 37]; however, 
others described an increased risk of lung cancer in sub-
group analyses [4]. The relation between dietary copper 
intake and lung cancer risk has been rarely reported among 
cohort studies. Similar to our results, only one cohort study 
reported no association between dietary copper intake and 
lung cancer [4].
Evidence has shown that selenium is a potent antioxi-
dant and may have anti-carcinogenic activity as well as 
selenium compounds are reported to induce toxicity and 
DNA damage [38]. However, our study and other previ-
ous prospective studies could not provide any support for a 
beneficial role of selenium on lung cancer risk [4, 39, 40]. 
Similarly, a selenium and lung cancer meta-analyses did 
not observe protective effect in studies assessing serum or 
dietary selenium but only in studies involving toenail sele-
nium [41]. Also, a recent study showed a nonlinear associa-
tion between selenium intake and esophageal cancer [30]. 
Furthermore, animal studies reported a different distribu-
tion of selenium between organs which suggest that benefit 
or risk differs from organ to organ [42]. In addition, data 
from previous studies show the influence of single-nucle-
otide polymorphisms in selenoprotein genes in lung cancer 
[43].
Our study is the largest cohort study to date with a long 
follow-up period (22 years) and which mutually investi-
gate the association between dietary zinc, iron, calcium, 
copper, magnesium and selenium and lung cancer. In com-
parison with previous studies, our population was relatively 
homogenous with regard to external air quality, since all 
participants lived in the same district. Another strength 
is that we adjusted for a broad range of confounders tak-
ing into account also overall dietary quality and socioeco-
nomic status (as a proxy also for occupational exposures). 
Furthermore, we were able to examine the associations of 
mineral intake with subtypes of lung cancer which did not 
show any difference. Nevertheless, there are several limita-
tions that need to be taken into account. FFQs are known 
to have measurement errors. This mainly leads to biased 
results toward the null in estimating diet–disease risk. In 
addition, diet and supplement intake were assessed once at 
baseline and might not reflect long-term dietary exposures 
as would be expected from repeated assessments of diet 
during follow-up. However, it has been shown that although 
dietary intake may change due to development of diseases 
over time, using baseline diet instead of repeated measures 
of diet usually leads to an underestimation instead of an 
overestimation of the true association [44]. Furthermore, 
while dietary intake of selenium has been shown to alter 
plasma levels of selenium, it is not certain to which degree 
the intake of other minerals examined in this study reflects 
their status in the human body [45]. Also, we did not have 
biomarkers of mineral status in the body, which may be 
optimal to elucidate the role of minerals in the etiology of 
lung cancer. Moreover, due to limited number of lung can-
cer cases, we could not perform comprehensive subgroup 
analysis by smoking status to elucidate any potential inter-
play between mineral intake and smoking. Therefore, we 
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cannot exclude residual confounding by smoking. We stud-
ied 6 different minerals in relation to lung cancer. However, 
it can be argued that this may lead to type I errors since 
we did not adjust the significance level for. Hence, cautious 
interpretation of P values is necessary.
In conclusion, our results suggest that a diet rich in zinc 
and iron may be associated with a decreased risk of lung 
cancer, whereas no evidence was found for other minerals. 
However, dietary mineral intake and the risk of lung cancer 
remain an understudied area of research, and further pro-
spective studies are needed to better understand the possi-
ble role of minerals in lung carcinogenesis.
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